Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -14.21% is 50% above its 5-year average of -28.55%, near the high end of its 5-year range (-142.03%–1.38%).
As of the fiscal period ended Tuesday, June 30, 2026. 2.26% above its 12-month average of -14.54%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q4 FY2026 (2026-06-30): -14.21%.
RETURN ON INVESTED CAPITAL (ROIC)
-14.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-14.54%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-11.75%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-28.55%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-55.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-58.80%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-65.90%
CURRENT VS TTM AVG
+2.26%
CURRENT VS 3Y AVG
-20.93%
CURRENT VS 5Y AVG
+50.21%
CURRENT VS 10Y AVG
+74.30%
CURRENT VS 15Y AVG
+75.83%
CURRENT VS 20Y AVG
+78.43%
SECTOR MEDIAN · HEALTHCARE
-27.25%
median of 439 covered companies
CURRENT VS SECTOR MEDIAN
+47.84%
vs the sector median at left
Aytu BioPharma, Inc.
Market Cap
$21.90M
Return on Invested Capital (ROIC)
-14.21%
TTM Avg
-14.54%
3Y Avg
-11.75%
5Y Avg
-28.55%
Market Cap
$20.93M
Return on Invested Capital (ROIC)
-1489.99%
TTM Avg
-2573.36%
3Y Avg
-1757.31%
5Y Avg
-1757.31%
Market Cap
$24.44M
Return on Invested Capital (ROIC)
-146.30%
TTM Avg
-66.51%
3Y Avg
-47.74%
5Y Avg
-43.26%
Market Cap
$18.82M
Return on Invested Capital (ROIC)
-46.69%
TTM Avg
-40.71%
3Y Avg
-34.73%
5Y Avg
-24.39%
Market Cap
$18.77M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-171.06%
3Y Avg
-106.73%
5Y Avg
-106.73%
Market Cap
$25.48M
Return on Invested Capital (ROIC)
-53.34%
TTM Avg
-80.89%
3Y Avg
-129.43%
5Y Avg
-113.96%
Market Cap
$16.58M
Return on Invested Capital (ROIC)
-85.72%
TTM Avg
-120.02%
3Y Avg
-101.35%
5Y Avg
-83.66%
Market Cap
$16.54M
Return on Invested Capital (ROIC)
-279.48%
TTM Avg
-96.52%
3Y Avg
-105.30%
5Y Avg
-89.17%
Market Cap
$27.31M
Return on Invested Capital (ROIC)
-42.23%
TTM Avg
-23.50%
3Y Avg
-191.16%
5Y Avg
-191.16%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aytu BioPharma, Inc. (AYTU) | $21.90M | -14.21% | -14.54% | -11.75% | -28.55% |
| Actuate Therapeutics Inc (ACTU)vs › | $20.93M | -1489.99% | -2573.36% | -1757.31% | -1757.31% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | -146.30% | -66.51% | -47.74% | -43.26% |
| Cosmos Health Inc. (COSM)vs › | $18.82M | -46.69% | -40.71% | -34.73% | -24.39% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | N/A | -171.06% | -106.73% | -106.73% |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.48M | -53.34% | -80.89% | -129.43% | -113.96% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.58M | -85.72% | -120.02% | -101.35% | -83.66% |
| Dyadic International, Inc. (DYAI)vs › | $16.54M | -279.48% | -96.52% | -105.30% | -89.17% |
| GridAI Technologies Corp. (GRDX)vs › | $27.31M | -42.23% | -23.50% | -191.16% | -191.16% |
| BioCardia, Inc. (BCDA)vs › | $16.22M | -273.70% | -707.06% | -535.27% | -358.40% |
ROIC
-14.2%
ROE
-40.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -14.21% |
| 2026-03-31 | -23.69% |
| 2025-12-31 | -12.84% |
| 2025-09-30 | -11.09% |
| 2025-06-30 | -10.87% |
| 2025-03-31 | -3.59% |
| 2024-12-31 | -13.56% |
| 2024-09-30 | -4.99% |
| 2024-06-30 | -4.88% |
| 2024-03-31 | 1.38% |
| 2023-12-31 | -8.97% |
| 2023-09-30 | -23.47% |
| 2023-06-30 | -22.00% |
| 2023-03-31 | -47.33% |
| 2022-12-31 | -96.72% |
| 2022-09-30 | -97.37% |
| 2022-06-30 | -142.03% |
| 2022-03-31 | -126.82% |
| 2021-12-31 | -60.48% |
| 2021-09-30 | -55.10% |
| 2021-06-30 | -32.56% |
| 2021-03-31 | -21.36% |
| 2020-12-31 | -14.51% |
| 2020-09-30 | -16.44% |
| 2020-06-30 | -16.84% |
| 2020-03-31 | -15.79% |
| 2019-12-31 | -31.61% |
| 2019-09-30 | -72.89% |
| 2019-06-30 | -57.40% |
| 2019-03-31 | -47.56% |
| 2018-12-31 | -51.18% |
| 2018-09-30 | -130.31% |
| 2018-06-30 | -111.52% |
| 2018-03-31 | -90.71% |
| 2017-12-31 | -103.86% |
| 2017-09-30 | -83.46% |
| 2017-06-30 | -144.14% |
| 2017-03-31 | -225.48% |
| 2016-12-31 | -183.65% |
| 2016-09-30 | -222.39% |
| 2016-06-30 | -152.43% |
| 2016-03-31 | -56.21% |
| 2015-12-31 | -33.96% |
| 2011-08-31 | -799.87% |
| 2011-05-31 | -369.61% |
| 2009-08-31 | -136.04% |
| 2008-11-30 | -116.65% |
| 2008-08-31 | -74.23% |
| 2008-05-31 | -72.22% |
| 2008-02-29 | -57.05% |
| 2007-11-30 | -55.82% |
| 2007-08-31 | -88.13% |
